Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients

Objective To evaluate the efficacy and safety of lasmiditan in Japanese adults with migraine. Background Global clinical studies have demonstrated the efficacy and safety of lasmiditan in the acute treatment of migraine. Methods This was a multicenter, randomized, double‐blind, placebo‐controlled, p...

Ausführliche Beschreibung